GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Symmetry Surgical Inc (FRA:RZV) » Definitions » Piotroski F-Score

Symmetry Surgical (FRA:RZV) Piotroski F-Score : 5 (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Symmetry Surgical Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Symmetry Surgical has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Symmetry Surgical's Piotroski F-Score or its related term are showing as below:

FRA:RZV' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Symmetry Surgical was 8. The lowest was 2. And the median was 5.


Symmetry Surgical Piotroski F-Score Historical Data

The historical data trend for Symmetry Surgical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symmetry Surgical Piotroski F-Score Chart

Symmetry Surgical Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 5.00 3.00 6.00 5.00

Symmetry Surgical Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 5.00 5.00 5.00

Competitive Comparison of Symmetry Surgical's Piotroski F-Score

For the Medical Devices subindustry, Symmetry Surgical's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Symmetry Surgical's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Symmetry Surgical's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep14) TTM:Last Year (Sep13) TTM:
Net Income was -1.575 + 0.907 + -4.822 + 1.022 = €-4.5 Mil.
Cash Flow from Operations was 8.614 + 3.545 + 9.388 + 12.552 = €34.1 Mil.
Revenue was 79.934 + 73.216 + 74.521 + 74.446 = €302.1 Mil.
Gross Profit was 18.458 + 17.308 + 20.729 + 19.953 = €76.4 Mil.
Average Total Assets from the begining of this year (Sep13)
to the end of this year (Sep14) was
(392.752 + 376.56 + 381.228 + 378.41 + 396.787) / 5 = €385.1474 Mil.
Total Assets at the begining of this year (Sep13) was €392.8 Mil.
Long-Term Debt & Capital Lease Obligation was €132.4 Mil.
Total Current Assets was €117.3 Mil.
Total Current Liabilities was €41.0 Mil.
Net Income was 2.227 + -0.227 + 0.892 + -25.824 = €-22.9 Mil.

Revenue was 81.196 + 76.323 + 75.053 + 71.559 = €304.1 Mil.
Gross Profit was 22.033 + 19.411 + 20.198 + 18.878 = €80.5 Mil.
Average Total Assets from the begining of last year (Sep12)
to the end of last year (Sep13) was
(475.512 + 461.252 + 465.111 + 449.941 + 392.752) / 5 = €448.9136 Mil.
Total Assets at the begining of last year (Sep12) was €475.5 Mil.
Long-Term Debt & Capital Lease Obligation was €131.8 Mil.
Total Current Assets was €103.8 Mil.
Total Current Liabilities was €40.1 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Symmetry Surgical's current Net Income (TTM) was -4.5. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Symmetry Surgical's current Cash Flow from Operations (TTM) was 34.1. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep13)
=-4.468/392.752
=-0.01137614

ROA (Last Year)=Net Income/Total Assets (Sep12)
=-22.932/475.512
=-0.04822591

Symmetry Surgical's return on assets of this year was -0.01137614. Symmetry Surgical's return on assets of last year was -0.04822591. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Symmetry Surgical's current Net Income (TTM) was -4.5. Symmetry Surgical's current Cash Flow from Operations (TTM) was 34.1. ==> 34.1 > -4.5 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep14)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep13 to Sep14
=132.357/385.1474
=0.34365285

Gearing (Last Year: Sep13)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep12 to Sep13
=131.756/448.9136
=0.29349968

Symmetry Surgical's gearing of this year was 0.34365285. Symmetry Surgical's gearing of last year was 0.29349968. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep14)=Total Current Assets/Total Current Liabilities
=117.337/40.97
=2.86397364

Current Ratio (Last Year: Sep13)=Total Current Assets/Total Current Liabilities
=103.761/40.121
=2.58620174

Symmetry Surgical's current ratio of this year was 2.86397364. Symmetry Surgical's current ratio of last year was 2.58620174. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Symmetry Surgical's number of shares in issue this year was 37.094. Symmetry Surgical's number of shares in issue last year was 36.345. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=76.448/302.117
=0.25304104

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=80.52/304.131
=0.26475433

Symmetry Surgical's gross margin of this year was 0.25304104. Symmetry Surgical's gross margin of last year was 0.26475433. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep13)
=302.117/392.752
=0.76923097

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep12)
=304.131/475.512
=0.63958638

Symmetry Surgical's asset turnover of this year was 0.76923097. Symmetry Surgical's asset turnover of last year was 0.63958638. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+1+1+0+1+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Symmetry Surgical has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Symmetry Surgical  (FRA:RZV) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Symmetry Surgical Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Symmetry Surgical's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Symmetry Surgical (FRA:RZV) Business Description

Traded in Other Exchanges
N/A
Address
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.

Symmetry Surgical (FRA:RZV) Headlines